2m 2m 2m 2m 2m 2m 2m
CONCORMED SP ADR (CCM)
NYSE
$4.48-$0.03 (-0.67%)
Price as of Jun 03, 2026 4:10 PM EDT- $13.9MMarket Cap
- -32.92%1-Year Change
- Medical Care FacilitiesIndustry
CONCORMED SP ADR (CCM)
$4.48-$0.03 (-0.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 460.5M +19.94% | 384.0M -28.55% | 537.4M +10.66% | 485.6M +117.76% | |
Cost of Revenue | 434.7M -6.14% | 463.1M -24.57% | 614.0M +13.18% | 542.5M +158.44% | |
Gross Profit | 25.8M +132.62% | -79.2M +3.33% | -76.6M +34.64% | -56.9M -534.89% | |
Sales and Marketing Expense | 52.2M +7.32% | 48.6M -13.63% | 56.3M +4.89% | 53.7M +108.36% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 36.1M -0.64% | 36.4M -0.95% | 36.7M +21.66% | 30.2M +91.49% | |
Total Operating Expenses | 213.0M -47.33% | 404.4M +22.51% | 330.1M -5.08% | 347.7M +17.95% | |
Operating Profit | -261.5M -50.86% | -532.2M +14.94% | -463.0M +1.02% | -458.3M +45.04% | |
Interest Income | 7.2M -2.73% | 7.4M -32.06% | 10.8M +83.78% | 5.9M -30.17% | |
Interest Expense | -152.3M -21.16% | -193.2M +16.62% | -165.7M +124.52% | -73.8M -9.30% | |
Interest Income and Expense and Net | -145.2M -21.89% | -185.8M +20.02% | -154.8M +128.05% | -67.9M -6.89% | |
Total Nonoperating Income and Expense | -7.7M -16.87% | -9.3M -14.53% | -10.8M +786.26% | -1.2M -119.38% | |
Income before Taxes | -373.4M -44.24% | -669.6M +20.52% | -555.6M +4.98% | -529.2M +19.83% | |
Income Taxes | 6.1M +134.64% | -17.5M -28.76% | -24.6M +274.30% | -6.6M -82.55% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Net Income | -92.8M -69.89% | -308.2M +3.56% | -297.7M +9.66% | -271.4M -12.44% | |
Net Income from Continuing Operations Applicable to Common | -92.8M -69.89% | -308.2M +3.56% | -297.7M +9.66% | -271.4M -12.44% | |
Basic EPS and Net Income | -0.71 -69.79% | -2.35 +3.52% | -2.27 -63.74% | -6.26 +22.50% | |
Diluted EPS and Net Income | -0.71 -69.79% | -2.35 +3.52% | -2.27 -63.74% | -6.26 +22.50% | |
Basic Weighted Average Shares | 131.1M 0.00% | 131.1M 0.00% | 131.1M 0.00% | 131.1M 0.00% | |
Diluted Weighted Average Shares | 131.1M 0.00% | 131.1M 0.00% | 131.1M 0.00% | 131.1M 0.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 297.8M +37.72% | 216.2M +271.91% | 58.1M -63.06% | 157.4M -52.92% | |
Short-Term Investments | 1,000 -100.00% | 134.6M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 297.8M -15.12% | 350.8M +503.46% | 58.1M -63.06% | 157.4M -52.92% | |
Total Current Assets | 941.9M -4.27% | 984.0M +59.42% | 617.2M +5.60% | 584.5M -13.54% | |
Accumulated Depreciation | 490.7M +24.45% | 394.3M +2.40% | 385.0M +71.22% | 224.9M +0.24% | |
Property and Plant and Equipment and Net | 3.7B +0.55% | 3.7B +4.44% | 3.5B +12.78% | 3.1B +22.89% | |
Total Long-Term Assets | 5.6B -2.39% | 5.7B +5.62% | 5.4B -3.70% | 5.6B +21.19% | |
Total Assets | 6.5B -2.66% | 6.7B +11.11% | 6.1B -2.83% | 6.2B +16.79% | |
Income Taxes Payable | 82.6M -2.27% | 84.5M -16.39% | 101.1M -45.20% | 184.4M +19.60% | |
Total Short-Term Debt | 981.1M -5.00% | 1.0B -0.91% | 1.0B +248.15% | 299.4M +101.07% | |
Total Current Liabilities | 2.0B -8.04% | 2.1B +8.91% | 2.0B +142.55% | 804.5M +57.10% | |
Total Long-Term Debt | 103.2M +8.09% | 95.5M -95.21% | 2.0B -8.47% | 2.2B +10.70% | |
Total Long-Term Liabilities | 2.7B -8.06% | 3.0B +26.65% | 2.4B -12.16% | 2.7B +10.74% | |
Total Liabilities | 4.7B -8.05% | 5.1B +18.61% | 4.3B +23.54% | 3.5B +18.83% | |
Retained Earnings | -4.5B +2.12% | -4.4B +7.58% | -4.1B +24.02% | -3.3B +33.40% | |
Total Stockholders Equity | -2.1B -7.77% | -2.3B +7.47% | -2.1B +54.87% | -1.4B +106.67% | |
Total Shares Outstanding | 84.5M 0.00% | 84.5M -67.58% | 260.5M 0.00% | 260.5M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -201.8M -49.26% | -397.7M +43.87% | -276.5M -23.06% | -359.3M +56.38% | |
Capital Expenditures | 56.3M -62.64% | 150.8M +33.42% | 113.0M -59.49% | 279.0M +66.04% | |
Cash from Investing Activities | 54.0M +109.09% | -593.4M +1,144.61% | -47.7M -91.58% | -566.0M +6.01% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 197.2M -82.79% | 1.1B +344.80% | 257.7M -59.90% | 642.4M -43.56% | |
Financials Ratio | |||||
Gross Margin | 5.61% +127.19% | -20.62% N/A | N/A N/A | -11.72% -299.71% | |
Operating Margin | -56.78% -59.03% | -138.60% N/A | N/A N/A | -94.38% -33.40% | |
Return on Assets | -1.40% -71.01% | -4.82% N/A | N/A N/A | -4.69% -27.07% | |
Return on Equity | 4.23% -69.76% | 14.00% N/A | N/A N/A | 26.70% -66.16% | |
Revenue Growth | 19.94% +169.83% | -28.55% N/A | N/A N/A | 117.76% +847.73% | |
Current Ratio | 0.48 +4.08% | 0.46 N/A | N/A N/A | 0.73 -44.96% | |
Cash Ratio | 0.15 +49.85% | 0.10 N/A | N/A N/A | 0.20 -70.03% | |
Debt-to-Equity Ratio | -0.52 +4.22% | -0.49 N/A | N/A N/A | -1.81 -43.36% | |
Debt-to-Assets Ratio | 0.17 -1.25% | 0.17 N/A | N/A N/A | 0.40 +0.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow